Neurocrine Biosciences

This study tested whether an investigational drug called NBI-1070770 could help reduce symptoms of major depression. It involved 73 adults with depression who continued taking their current antidepressant medications throughout the trial. Researchers compared the new drug against…

This study tested whether a new drug called NBI-827104 could help children with a rare and severe form of epilepsy that causes continuous abnormal brain waves during sleep. 24 children participated, taking the drug or a placebo daily for 13 weeks. The main goal was to see if the …

This study tested whether adding a drug called valbenazine to a person's current antipsychotic medication could better control schizophrenia symptoms. It involved 442 adults whose symptoms weren't fully controlled by their existing medication. Participants were randomly assigned …

This study tested whether the drug valbenazine could improve daily life for people with tardive dyskinesia (TD), a condition causing uncontrollable movements often linked to certain mental health medications. For 24 weeks, 59 adults with TD and conditions like schizophrenia or bi…